• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION ROTABLATOR ROTATIONAL ATHERECTOMY SYSTEM; CATHETER, CORONARY, ATHERECTOMY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION ROTABLATOR ROTATIONAL ATHERECTOMY SYSTEM; CATHETER, CORONARY, ATHERECTOMY Back to Search Results
Device Problems Material Integrity Problem (2978); Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Ventricular Fibrillation (2130); Perforation of Vessels (2135); Cardiac Tamponade (2226)
Event Date 01/01/2023
Event Type  Injury  
Event Description
It was reported that coronary perforation occurred and patient experienced cardiac tamponade and ventricular fibrillation.The stenosed target lesion was located in the severely calcified proximal left anterior descending artery.A rotablator burr was selected for use.During the procedure, extravasation of contrast medium was observed after the passage of the rotaburr.Immediately, the perfusion balloon was dilated at the left anterior descending proximal site.However, the bleeding could not stop.Consequently, the blood pressure decreased due to cardiac tamponade and ventricular fibrillation occurred.Drainage was attempted but it could not be achieved.Venoarterial extracorporeal membrane oxygenation (v-a ecmo) was introduced.Intravascular ultrasound (ivus) findings showed that the vessel wall on the left circumflex side disappeared from the left main trunk to the proximal left anterior descending artery, and there was no connection between the left circumflex and the main trunk.A covered stent crossing over the left circumflex was necessary to stop the bleeding.A covered stent was placed from left main trunk to left anterior descending artery.After stenting, bleeding stopped, and patient's condition has improved.Patient was transferred to another hospital for coronary artery bypass graft (cabg).
 
Manufacturer Narrative
Date of event: (b)(6) 2023 was used as an approximate event date, as the actual event date is unknown.
 
Manufacturer Narrative
Date of event: 01/01/2023 was used as an approximate event date, as the actual event date is unknown.
 
Event Description
It was reported that coronary perforation occurred and patient experienced cardiac tamponade and ventricular fibrillation.The stenosed target lesion was located in the severely calcified proximal left anterior descending artery.A rotablator burr was selected for use.During the procedure, extravasation of contrast medium was observed after the passage of the rotaburr.Immediately, the perfusion balloon was dilated at the left anterior descending proximal site.However, the bleeding could not stop.Consequently, the blood pressure decreased due to cardiac tamponade and ventricular fibrillation occurred.Drainage was attempted but it could not be achieved.Venoarterial extracorporeal membrane oxygenation (v-a ecmo) was introduced.Intravascular ultrasound (ivus) findings showed that the vessel wall on the left circumflex side disappeared from the left main trunk to the proximal left anterior descending artery, and there was no connection between the left circumflex and the main trunk.A covered stent crossing over the left circumflex was necessary to stop the bleeding.A covered stent was placed from left main trunk to left anterior descending artery.After stenting, bleeding stopped, and patient's condition has improved.Patient was transferred to another hospital for coronary artery bypass graft (cabg).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ROTABLATOR ROTATIONAL ATHERECTOMY SYSTEM
Type of Device
CATHETER, CORONARY, ATHERECTOMY
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC LTD
model farm road
cork
EI  
Manufacturer Contact
rachel shields
4100 hamline ave n
arden hills, MN 55112
6512422111
MDR Report Key17744283
MDR Text Key323385028
Report Number2124215-2023-49045
Device Sequence Number1
Product Code MCX
Combination Product (y/n)N
Reporter Country CodeJA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Literature,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 10/02/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 08/18/2023
Initial Date FDA Received09/14/2023
Supplement Dates Manufacturer Received09/14/2023
Supplement Dates FDA Received10/02/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age60 YR
Patient SexFemale
-
-